Are rheumatoid arthritis patients more willing to accept non-steroidal anti-inflammatory drug treatment risks than osteoarthritis patients?

British Journal of Rheumatology

Volumn 36, Issue 4, 1997, Pages 470-472

  Bagge, E ^a   Traub, M ^a   Crotty, M ^a   Conaghan, P G ^a   Oh, E ^a   Brooks, P M ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Acceptance; Benefits; Expectations; NSAIDs; Treatment risks

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; DRUG EFFICACY; EXPECTATION; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTERVIEW; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SIDE EFFECT; ULCER;

EID: 0030737645     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.4.470     Document Type: Article

References (20)

1. Henry DA. Side effects of non-steroidal antiinflammatory drugs. Baillière's Clin Rheumatol 1988;2:425-54.
2. Brooks PM. Management of rheumatic diseases. Pharmacological approaches. NSAIDs. In: Klippel JH, Dieppe PA, eds. Rheumatology. London: Fiona Foley, 1994:Section 8, 10.1-6.
3. Fries JF, Miller SR, Spitz PW, Williams CA et al. Towards an epidemiology of gastropathy associated with non-steroidal antiinflammatory drug use. Gastroenterology 1989;96(suppl. 2):647-55.
4. Langman MJS, Veil J, Wainwright P el al. Risks of bleeding peptic ulcer associated with individual non-steroidal antiinflammatory drugs. Lancet 1994;363: 1075-8.
5. Brooks PM, Day RO. Non-steroidal antiinflammatory drugs - differences and similarities. N Engl J Med 1991;324:1716-25.
6. Preston SJ, Arnold MH, Beller EM et al. Variability in response to non-steroidal antiinflammatory analgesics: evidence from controlled clinical therapeutic trial of flurbiprofen in rheumatoid arthritis. Br J Clin Pharmacol 1988;26:759-64.
7. O'Brien J, Elswood J, Calin A. Willingness to accept risks in the treatment of rheumatic disease. J Epidemiol Community Health 1990;44:249-52.
8. Altman R. Classification of disease: Osteoarthritis. Semin Arthritis Rheum 1991;20:40-7.
9. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
10. Pincus T, Marcum SB, Callahan LF et al. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: Non-steroidal antiinflammatory drugs. J Rheumatol 1992;19:1874-84.
11. Luggen ME, Gartside PS, Hess EV. Non-steroidal antiinflammatory drugs in rheumatoid arthritis: duration of use as a measure of relative value. J Rheumatol 1989;16:1565-9.
12. Wijnands M, van Riel P, Van't Hof M, Gribnau F, Van der Putte L. Longterm treatment with nonsteroidal antiinflammatory drugs in rheumatoid arthritis: a prospective survival study. J Rheumatol 1991;18:184-7.
13. Llewellyn-Thomas HA, Sutherland HJ, Tibshirani R. The measurement of patients values in medicine. Am J Public Health 1986;76:392-6.
14. Thomson MS. Willingness to pay risks to cure chronic disease. Am J Public Health 1986;76:392-6.
15. O'Brian BJ, Elswood J, Calin A. Perception of prescribing drug risks: a survey of patients with ankylosing spondylitis. J Rheumatol 1990;17:503-7.
16. Pincus T, Callahan LF. Formal education as a marker for increased mortality and morbidity in rheumatoid arthritis. J Chronic Dis 1985;38:973-84.
17. Callahan LF, Pincus T. Formal educational level as a significant marker of clinical status in rheumatoid arthritis. Arthritis Rheum 1988;31:1346-57.
18. Leigh JP, Fries JF. Education level and rheumatoid arthritis: evidence from five data centres. J Rheumatol 1991;18:24-34.
19. Lorig K, Fries JF. A tested self management program for coping with your arthritis. In: Reading JHK, ed. The arthritis help book. Reading, MA: Addison-Wesley, 1980.
20. Lindroth Y, Bauman A, Barnes C, McCredie M, Brooks PM. A controlled evaluation of arthritis education. Br J Rheumatol 1989;28:7-12.